[COVID-19 trials: surfing between expectations and illusions, looking forward to evidence]

G Ital Cardiol (Rome). 2020 Jul;21(7):479-482. doi: 10.1714/3386.33632.

[Article in Italian]

Authors

Giuseppe Di Pasquale¹, Aldo P Maggioni²

Affiliations

¹ Editor, Giornale Italiano di Cardiologia.
² Centro Studi ANMCO, Fondazione per il Tuo cuore, Firenze.

PMID: 32555562
DOI: 10.1714/3386.33632

No abstract available

Publication types

Review

MeSH terms

Adenosine Monophosphate / administration & dosage
Adenosine Monophosphate / analogs & derivatives*
Alanine / administration & dosage
Alanine / analogs & derivatives*
COVID-19
Coronavirus Infections / drug therapy*
Coronavirus Infections / epidemiology
Coronavirus Infections / prevention & control*
Female
Humans
Hydroxychloroquine / administration & dosage*
Italy / epidemiology
Male
Pandemics / prevention & control*
Pandemics / statistics & numerical data
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / prevention & control*
Prevalence
Randomized Controlled Trials as Topic
Risk Assessment

Substances

remdesivir
Adenosine Monophosphate
Hydroxychloroquine
Alanine